ProfileGDS4132 / 212180_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 91% 92% 93% 90% 92% 92% 90% 93% 92% 91% 91% 93% 94% 93% 89% 91% 92% 90% 92% 91% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101432.93591
GSM201543Muscle PCOS pioglitazone 121449.46892
GSM201544Muscle PCOS pioglitazone 161586.26993
GSM201545Muscle PCOS pioglitazone 201458.70290
GSM201829Muscle PCOS pioglitazone 231496.51692
GSM201830Muscle PCOS pioglitazon 251505.5292
GSM201831Muscle PCOS pioglitazone 271433.78490
GSM201832Muscle PCOS pioglitazone 31570.89293
GSM201833Muscle PCOS pioglitazone 41519.80892
GSM201834Muscle PCOS pioglitazone 81472.85491
GSM201835Muscle PCOS after pioglitazone 102480.85991
GSM201836Muscle PCOS after pioglitazone 122595.74793
GSM201837Muscle PCOS after pioglitazone 162659.99694
GSM201838Muscle PCOS after pioglitazone 202657.18693
GSM201839Muscle PCOS after pioglitazone 232422.40889
GSM201840Muscle PCOS after pioglitazone 252516.24591
GSM201841Muscle PCOS after pioglitazone 272535.68492
GSM201842Muscle PCOS after pioglitazone 32454.99490
GSM201843Muscle PCOS after pioglitazone 42515.87892
GSM201844Muscle PCOS after pioglitazone 82503.79791